Skip to main content
Caplight Logo









Roca Therapeutics

Roca Therapeutics

Private
NiceHealthcare & Life Scienceshttps://www.roca-therapeutics.org/

Last Round

Grant

May 6, 2024

Total Funding Raised

$1.19M

Company Overview

Roca Therapeutics is a biotechnology company developing first-in-class, non-invasive small molecule therapies for severe ocular diseases and cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

small molecule therapyradiation maculopathyfirst-in-class therapynon-invasive therapyclinical-stage biotechtherapeutic eye dropsmetastatic uveal melanomaophthalmologydrug developmentorphan drugrare disease treatmentdisease-modifying therapyoncologydiabetic macular edema

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Roca Therapeutics Comparables

Compare Roca Therapeutics with similar companies based on industry and business-model similarity.

Roca Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Exonate
86%
Oculis Holding
77%
Kyowa Kirin
70%

Roca Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 6, 2024
Series ASep 22, 2022
SeedSep 22, 2022

Roca Therapeutics Investors

Notable investors and investment history

Roca Therapeutics investors
InvestorRounds
SATT Sud-EstSeed
European UnionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 69% MoM.

  • Sep 22, 2022

    Seed round led by SATT Sud-Est.

Roca Therapeutics Filings

Explore SEC and related filing metadata, where available.

Roca Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Roca Therapeutics's valuation, stock price, and market status.

Is Roca Therapeutics a public or private company?

Roca Therapeutics is a private company.

What is the current stock price of Roca Therapeutics?

Roca Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Roca Therapeutics worth (valuation)?

Valuation information for Roca Therapeutics is not publicly available.

Can I buy Roca Therapeutics stock?

Roca Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Roca Therapeutics's last funding round?

Funding round information for Roca Therapeutics is not publicly available.

Who are the main investors in Roca Therapeutics?

Investor information for Roca Therapeutics is not publicly disclosed.

Will Roca Therapeutics IPO soon?

No public IPO plans have been announced for Roca Therapeutics.

How can I track Roca Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Roca Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNice
Employee Range7
Year Founded2021
Last FundingMay 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?